(Q40810564)

23 September 2017

title

VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death (English)

1 reference

23 September 2017

0 references

Liu CS

1

1 reference

23 September 2017

Kong B

2

1 reference

23 September 2017

Xia HH

3

1 reference

23 September 2017

Ellem KA

4

1 reference

23 September 2017

Wei MQ

5

1 reference

23 September 2017

publication date

1 March 2001

1 reference

23 September 2017

published in

Journal of Gene Medicine

1 reference

23 September 2017

volume

3

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

145-152

1 reference

Direct cell killing by suicide genes

23 September 2017

cites work

1 reference

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

21 January 2018

1 reference

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

21 January 2018

1 reference

Gene therapy -- promises, problems and prospects

21 January 2018

1 reference

Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment

21 January 2018

1 reference

Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy

21 January 2018

1 reference

Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma

21 January 2018

1 reference

Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats.

21 January 2018

1 reference

In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.

21 January 2018

1 reference

The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer

21 January 2018

1 reference

Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene

21 January 2018

1 reference

Intercellular trafficking and protein delivery by a herpesvirus structural protein

21 January 2018

1 reference

The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49

21 January 2018

1 reference

Phosphorylation of the herpes simplex virus type 1 tegument protein VP22.

21 January 2018

1 reference

Overexpression of the herpes simplex virus type 1 tegument protein VP22 increases its incorporation into virus particles

21 January 2018

1 reference

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

21 January 2018

1 reference

Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells

21 January 2018

1 reference

Sustained gene expression in transplanted skin fibroblasts in rats

21 January 2018

1 reference

High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site

21 January 2018

1 reference

Intercellular trafficking of VP22-GFP fusion proteins

21 January 2018

1 reference

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.

21 January 2018

1 reference

Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model

21 January 2018

1 reference

Heterogeneity in the HeLa cell cycle response to UVC analyzed by the BrdUrd two-parameter method

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JGM.164

1 reference

23 September 2017

1 reference